Conivaptan hydrochloride (Conivaptan HCl, YM 087, YM087)，又称盐酸考尼伐坦，是非肽类抗利尿激素抑制剂，是加压素受体(vasopressin receptor) V1a和V2的抑制剂，临床上用于治疗高容量性低钠血症。

参考文献

[1] Wada K, et al. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure. Eur J Pharmacol. 2005 Jan 10;507(1-3):145-51.

[2] Yatsu T, et al. Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure. Eur J Pharmacol. 1999 Jul 9;376(3):239-46.

冰袋运输。粉末直接保存于-25~-15℃，有效期3年。建议分装后-25~-15℃干燥保存，避免反复冻融。